专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20180036360A1 IMMUNOLOGICALLY ACTIVE PHYTO-MIXTURE AND ITS USE IN THE PREVENTION AND IN A METHOD FOR TREATMENT OF EFFLORESCENCES 审中-公开
公开(公告)号：US20180036360A1
公开(公告)日：2018-02-08
申请号：US15550600
申请日：2016-02-10
申请人： Renate Wilmanowicz
发明人： Renate Wilmanowicz
IPC分类号： A61K36/28 , A61K8/97 , A61K36/85 , A61K36/886 , A61K36/32 , A61K36/68
CPC分类号： A61K36/28 , A61K8/97 , A61K36/32 , A61K36/68 , A61K36/85 , A61K36/886 , A61K2300/00
摘要： The present invention relates to an immunologically active phyto-mixture comprising at least one plant extract selected from the family a) Asteraceae, b) Verbenaceae, and/or c) Burseraceae, preferably at least one plant extract from the genus a) Bidens, b) Stachytarpheta, and/or c) Bursera. Particularly preferred species include a) Bidens alba, Bidens pilosa, b) Stachytarpheta jamaicensis, Stachytarpheta cayennensis, Stachytarpheta indica, and/or c) Bursera simaruba, Bursera microphylla, Bursera glabrifolia. The phyto-mixture optionally comprises d) at least one further biologically active plant extract, such as Aloe vera and/or Stemodia maritima. The afore-mentioned phyto-mixture according to the invention exhibits good antimicrobial and anti-inflammatory efficiency and is particularly suitable for prevention and treatment of efflorescences. Therefore, the present invention also relates to a preparation for oral and topical administration for prevention and treatment of efflorescences of the skin and the mucous membrane.

2. 发明申请

US20170319475A1 Medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, preparation method therefor and use method thereof 审中-公开
公开(公告)号：US20170319475A1
公开(公告)日：2017-11-09
申请号：US14901060
申请日：2015-05-29
申请人： Darong LIU
发明人： Darong LIU
IPC分类号： A61K9/00 , A61K36/489 , A61K36/236 , A61K36/32 , A61K36/58 , A61K9/08 , A61K36/00
CPC分类号： A61K9/0053 , A61K9/0095 , A61K9/08 , A61K33/06 , A61K35/10 , A61K35/36 , A61K36/00 , A61K36/11 , A61K36/23 , A61K36/232 , A61K36/234 , A61K36/236 , A61K36/24 , A61K36/32 , A61K36/324 , A61K36/40 , A61K36/46 , A61K36/481 , A61K36/484 , A61K36/489 , A61K36/58 , A61K36/605 , A61K36/65 , A61K36/71 , A61K36/716 , A61K36/718 , A61K36/725 , A61K36/738 , A61K36/746 , A61K36/75 , A61K36/756 , A61K36/815 , A61K36/899 , A61K36/90 , A61K36/904 , A61K2300/00
摘要： The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use methods thereof. The medicine comprises: lightyellow sophora root, glabrous greenbrier rhizome, bark of Chinese corktree, raw sessile stemona root, alumen, coptis root, cortex dictamni, chinaberry bark and root-bark, pangolin scales, amber, eucommia bark, tree peony bark, clematis root, common cnidium fruit, Chinese angelica, licorice root, common macrocarpium fruit, barbary wolfberry fruit, medicinal indianmulberry root, cherokee rose fruit, chinaroot greenbier rhizome, akebia fruit, milkvetch root, Japanese climbing fern spore, asiatic pennywort herb, mulberry leaf and frankincense. The present invention not only provides the medicine capable of effectively treating the acquired immunodeficiency syndrome, but also enables the medicine to be capable of being used in conjunction with other medical technical means to easily achieve a more ideal treatment effect.

3. 发明授权

US08936817B2 Preparation for weight loss management 有权
标题翻译：准备减肥管理
公开(公告)号：US08936817B2
公开(公告)日：2015-01-20
申请号：US13695573
申请日：2011-05-03
申请人： Arun K. Chatterji
发明人： Arun K. Chatterji
IPC分类号： A61K36/324 , A61K36/27 , A61K36/328 , A61K36/59 , A61K36/32
CPC分类号： A61K36/324 , A61K36/27 , A61K36/32 , A61K36/328 , A61K36/59 , A61K2300/00
摘要： Gymnema sylvestre extracts together with extracts of one or more of Boswellia serrata, Tinospora cordifolia and Commiphora mukul provide effective weight loss management when administered to a patient desiring weight loss management. Administration of the foregoing also reduces the leptin-to-adiponectin ratio in the patient's blood serum.
摘要翻译：枸杞子提取物与一种或多种浆果提取物一起提取，同时提供有效的减肥管理。上述的给药还降低了患者血清中瘦素与脂联素的比例。

4. 发明申请

US20040208941A1 Compositions for removal of toxins 失效
标题翻译：去除毒素的组合物
公开(公告)号：US20040208941A1
公开(公告)日：2004-10-21
申请号：US10486817
申请日：2004-04-15
发明人： Michael Hargreaves Riley , Jane Clarissa Fletcher
IPC分类号： A61K035/78 , A61K031/7048 , A61K031/59 , A61K031/355 , A61K031/375 , A61K031/353
CPC分类号： A61K36/87 , A61K8/67 , A61K8/922 , A61K8/97 , A61K36/07 , A61K36/14 , A61K36/15 , A61K36/16 , A61K36/185 , A61K36/23 , A61K36/235 , A61K36/258 , A61K36/28 , A61K36/282 , A61K36/296 , A61K36/32 , A61K36/346 , A61K36/43 , A61K36/48 , A61K36/484 , A61K36/53 , A61K36/532 , A61K36/535 , A61K36/54 , A61K36/575 , A61K36/61 , A61K36/65 , A61K36/69 , A61K36/718 , A61K36/736 , A61K36/752 , A61K36/79 , A61K36/85 , A61K36/882 , A61K36/886 , A61K36/8965 , A61K36/8967 , A61K36/899 , A61K36/9068 , A61K2800/92 , A61Q17/00 , A61K2300/00
摘要： A medicinal or cosmetic composition comprising Aloe vera in combination with at least one vitamin, a minerals concentrate, an organic oils concentrate, at least one Chinese Herb, at least one essential oil and at least one spice. The composition may be administered orally or topically.
摘要翻译：一种药用或化妆品组合物，其包含与至少一种维生素，矿物质浓缩物，有机油浓缩物，至少一种中草药，至少一种精油和至少一种香料组合的芦荟。组合物可以口服或局部施用。

5. 发明授权

US06676952B2 Use of an okume resin extract in the cosmetic and pharmaceutical fields, and in particular in the dermatological field 有权
标题翻译：在化妆品和药物领域，特别是在皮肤病学领域中使用可可树脂提取物
公开(公告)号：US06676952B2
公开(公告)日：2004-01-13
申请号：US09319854
申请日：1999-06-11
申请人： Isabelle Renimel , Patrice Andre
发明人： Isabelle Renimel , Patrice Andre
IPC分类号： A61K600
CPC分类号： A61Q19/08 , A61K8/922 , A61K8/97 , A61K36/32 , A61Q1/02 , A61Q1/10 , A61Q3/00 , A61Q3/02 , A61Q5/00 , A61Q17/00 , A61Q19/00 , A61Q19/005 , A61K2300/00
摘要： The invention relates to novel uses of an extract of okume resin in the cosmetic and pharmaceutical fields, and in particular in the dermatological field. It relates to cosmetic compositions for treating the nails, the hair, or the eyelashes in order to maintain their keratin structure in good condition, for combatting aging of the skin, for combatting the harmful effects of free radicals, and for the care or makeup of sensitive skin. It also relates to dermatological compositions, more particularly compositions for preventing or treating diseases of the hair or the nails.
摘要翻译：本发明涉及在化妆品和药物领域，特别是在皮肤病学领域中的功能树脂提取物的新用途。它涉及用于治疗指甲，头发或睫毛的化妆品组合物，以便保持其角蛋白结构处于良好状态，用于抵抗皮肤老化，用于抵抗自由基的有害影响，以及用于护理或化妆敏感型皮肤。它还涉及皮肤病学组合物，更特别地涉及用于预防或治疗头发或指甲疾病的组合物。

6. 发明申请

US20160051610A1 Topical Pharmaceutical Bases for Treating Skin Conditions 有权
标题翻译：用于治疗皮肤病症的专用药物基剂
公开(公告)号：US20160051610A1
公开(公告)日：2016-02-25
申请号：US14831137
申请日：2015-08-20
申请人： Professional Compounding Centers of America (PCCA)
发明人： Daniel Banov
IPC分类号： A61K36/48 , A61K31/015 , A61K9/00 , A61K36/32 , A61K45/06
CPC分类号： A61K31/015 , A61K9/0014 , A61K36/32 , A61K36/47 , A61K45/06 , A61K47/14 , A61K47/44 , A61K2300/00
摘要： The present disclosure refers to topical pharmaceutical bases that possess scar healing properties. Further, these topical pharmaceutical bases are proposed for treating skin conditions, such as, for example keloids, hypertrophic scars, wounds, and burns, among others. The topical pharmaceutical bases include Amazonian oils and resins, such as pracaxi oil and breu-branco resin. The synergistic effect of pracaxi oil combined with breu-branco resin results in a highly effective scar and wound treatment. Suitable active pharmaceutical ingredients (APIs) can be incorporated to the topical pharmaceutical bases to formulate topical pharmaceutical compositions, which improve healing effects. The synergistic effect provided by the combination of pracaxi oil and breu-branco resin enables lower dosage requirements of the associated APIs when topical pharmaceutical compositions are employed for treating skin conditions.
摘要翻译：本公开涉及具有瘢痕愈合性质的局部药物基质。此外，提出这些局部药物基质用于治疗皮肤病症，例如瘢痕疙瘩，肥大性瘢痕，伤口和烧伤等。局部药物基础包括亚马逊油和树脂，如普拉克西斯油和布鲁姆树脂。普拉卡西克油与布鲁姆树脂组合的协同效应导致高效瘢痕和伤口治疗。合适的活性药物成分（API）可以掺入到局部药物基质中以配制改善愈合作用的局部药物组合物。当使用局部药物组合物用于治疗皮肤病症时，由普拉卡西油和布鲁克司林树脂组合提供的协同效应可以降低相关API的剂量需求。

7. 发明申请

US20160051607A1 Topical Pharmaceutical Bases for Preventing Viral Diseases 有权
标题翻译：专门用于预防病毒性疾病的药物基础
公开(公告)号：US20160051607A1
公开(公告)日：2016-02-25
申请号：US14831112
申请日：2015-08-20
申请人： Professional Compounding Centers of America (PCCA)
发明人： Daniel Banov
IPC分类号： A61K36/32 , A61K31/20 , A61K31/015
CPC分类号： A61K36/32 , A61K9/0014 , A61K31/015 , A61K31/20 , A61K36/47 , A61K2300/00
摘要： The present disclosure refers to topical pharmaceutical bases that possess antiviral properties. Further, these topical pharmaceutical bases are employed for preventing a patient to be infected by viral diseases. The topical pharmaceutical bases include Amazonian oils and resins, such as pracaxi oil and breu-branco resin. The synergistic effect of pracaxi oil combined with breu-branco resin results in a highly effective antiviral treatment. Suitable active pharmaceutical ingredients (APIs) can be incorporated to the topical pharmaceutical bases to formulate topical pharmaceutical compositions, which improve antiviral effects. The synergistic effect provided by the combination of pracaxi oil and breu-branco resin enables lower dosage requirements of the associated APIs when topical pharmaceutical compositions are employed for preventing viral diseases.
摘要翻译：本公开涉及具有抗病毒性质的局部药物基质。此外，这些局部药用碱基用于预防患者被病毒性疾病感染。局部药物基础包括亚马逊油和树脂，如普拉克西斯油和布鲁姆树脂。普拉卡西克油与布鲁姆树脂结合的协同效应导致高效抗病毒治疗。合适的活性药物成分（API）可以掺入到局部药物基质中以配制改善抗病毒作用的局部药物组合物。当使用局部药物组合物用于预防病毒性疾病时，由普拉卡西克油和布鲁克兰树脂组合提供的协同效应可以降低相关API的剂量需求。

8. 发明申请

US20130136814A1 PREPARATION FOR WEIGHT LOSS MANAGEMENT 有权
标题翻译：重量损失管理准备
公开(公告)号：US20130136814A1
公开(公告)日：2013-05-30
申请号：US13695573
申请日：2011-05-03
申请人： Arun K. Chatterji
发明人： Arun K. Chatterji
IPC分类号： A61K36/324 , A61K36/27 , A61K36/32 , A61K36/59
CPC分类号： A61K36/324 , A61K36/27 , A61K36/32 , A61K36/328 , A61K36/59 , A61K2300/00
摘要： Gymnema sylvestre extracts together with extracts of one or more of Boswellia serrata, Tinospora cordifolia and Commiphora mukul provide effective weight loss management when administered to a patient desiring weight loss management. Administration of the foregoing also reduces the leptin-to-adiponectin ratio in the patient's blood serum.
摘要翻译：枸杞子提取物与一种或多种浆果提取物一起提取，同时提供有效的减肥管理。上述的给药还降低了患者血清中瘦素与脂联素的比例。

9. 发明授权

US07195790B2 Modification of cyclooxygenase and lipoxygenase activity with asteridae extracts and optionally boswellic acid 有权
标题翻译：修饰环氧合酶和脂氧合酶活性与id科提取物和任选的硼酸
公开(公告)号：US07195790B2
公开(公告)日：2007-03-27
申请号：US10732182
申请日：2003-12-09
申请人： Peter X. Zhang , Michael T. Yatcilla
发明人： Peter X. Zhang , Michael T. Yatcilla
IPC分类号： A61K36/00
CPC分类号： A61K31/19 , A61K36/24 , A61K36/28 , A61K36/286 , A61K36/32 , A61K36/324 , A61K36/328 , A61K36/634 , A61K2300/00
摘要： Extracts from plants in the Asteridae subfamily, such as Carthamus tinctorious, are effective to selectively inhibit COX-2 activity and/or enhance COX-1 activity. When Asteridae extracts are combined with boswellic acid, the combination exhibits a synergistic inhibitory effect on both COX-2 and LO. Such extracts and combinations are used in methods of selectively inhibiting COX-2, inhibiting LO, and/or enhancing COX-1 activity as well as in the methods of treating conditions that would respond favorably to any of these effects.
摘要翻译：来自Asteridae亚科植物的提取物，例如赤丹藓，对选择性抑制COX-2活性和/或增强COX-1活性是有效的。当Asteridae提取物与boswellic酸组合时，组合对COX-2和LO都表现出协同抑制作用。这些提取物和组合用于选择性抑制COX-2，抑制LO和/或增强COX-1活性的方法中，以及在治疗对这些作用中的任何一种有利地响应的条件的方法中。

10. 发明授权

US06395313B1 Treatment of arthritis and other similar conditions 失效
标题翻译：治疗关节炎等相似病症
公开(公告)号：US06395313B1
公开(公告)日：2002-05-28
申请号：US09701503
申请日：2001-02-05
申请人： Peter Hugh Hull
发明人： Peter Hugh Hull
IPC分类号： A61K3578
CPC分类号： A61K36/32 , A61K2300/00
摘要： Methods for treatment of arthritis are provided, the methods including administering an effective amount of Ngali Nut Oil.
摘要翻译：提供了治疗关节炎的方法，所述方法包括施用有效量的Ngali Nut Oil。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式